(Available Commercially with reasonable lead time)
| S.No. | Product Name | CAS No | Therapeutic Category |
|---|---|---|---|
| 1 | (±)-4-Fluoro-a-(2-methyl-1-oxopropyl)-g-oxo-N, b-diphenyl benzene butanamide+B1:F4 | 125971-96-2 | Atorvastatin |
| 2 | tert-Butyl (4R,6R)-2-[[[6-(2-4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenyl carbamoyl) pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate (ATV-1) | 125971-95-1 | Atorvastatin |
| 3 | (4-Cyano phenyl) amino acetic acid | 42288-26-6 | Dabigatran |
| 4 | Ethyl-3{[3-amino-4-methylamino)benzoyl] (pyridine-2-yl) amino) propanoate | 212322-56-0 | Dabigatran |
| 5 | N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl] carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride | 211914-50-0 | Dabigatran |
| 6 | N-[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl] -N-2-pyridinyl-β-alanine Ethyl Ester | 211915-84-3 | Dabigatran |
| 7 | Dabigatran Etexilate (Base) | 211915-06-9/td> | Dabigatran |
| 8 | 2, 3, 4, 6-Tetrakis-O-trimethylsilyl-D-glucono-1,5-lactone | 32384-65-9 | Canagliflozin, Dapagliflozin, Empagliflozin, Ipragliflozin |
| 9 | 2-(4-ethoxybenzyl)-4-bromo-1-chloro benzene | 461432-23-5 | Dapagliflozin |
| 10 | (S)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran | 915095-89-5 | Empagliflozin |
| 11 | (S)-3-(4-(5-Iodo-2-chlorobenzyl)phenoxy)tetrahydrofuran | 915095-94-2 | Empagliflozin |
| 12 | tert-butyl(4-(2-chloro-5-iodobenzyl) phenoxy)dimethylsilane | 1800112-28-0 | Empagliflozin |
| 13 | p-Toluenesulfonylmethyl isocyanide | 36635-61-7 | Multiple Applications |
| 14 | 4,6 -Dichloro-2-methyl pyrimidine | 1780-26-3 | Dasatinib |
| 15 | 4,6-dichloro-2-propylthiopyrimidine-5-amine | 145783-15-9 | Ticagrelor |
| 16 | Vanillylamine Hydrochloride | 7149-10-2 | Capsaicin |
| 17 | 2-Butyl-4-Chloro-5-Formyl-1H-Imidazole | 83857-96-9 | Losartan Potassium |
| 18 | 2-(N-Triphenyl methyl tetrazyl)-4’-bromo methyl biphenyl(TTBB) | 133051-88-4 | Sartans |
| S.No. | Product Name | CAS No | Therapeutic Category |
|---|---|---|---|
| 1 | 3-AMINOPIPERIDINE-2,6-DIONE HYDROCHLORIDE | 24666-56-6 | Lenalidomide |
| 2 | METHYL-2(BROMOMETHYL)-3-NITROBENZOATE | 98475-07-1 | Lenalidomide |
| 3 | 4-Formyl-N-Cbz-piperidine | 138163-08-3 | Multiple applications |
| 4 | 2-Chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide | 1211443-61-6 | Ribociclib Intermediate |
| 5 | 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | 1211443-58-1 | Ribociclib Intermediate |
| 6 | Tert-Butyl4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | 571188-59-5 | Palbociclib/Ribociclib Intermediate |
| 7 | 4-[(4-Chloro-2-pyrimidinyl)amino]benzonitrile | 244768-32-9 | Rilpivirine |
| 8 | (E)-3-(4-Amino-3, 5-dimethylphenyl) acrylonitrile HCl | 661489-23-2 | Rilpivirine |
| 9 | (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4 chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro 2H-pyran-3,4,5-triyl triacetate | 461432-25-7 | Dapagliflozin |
| 10 | Ethyl 3-(2-(chloromethyl)-1-methyl-n-(pyridin-2-yl)-1h-benzo[d]imidazole-5-carboxamido)propanoate | 1307233-94-8 | Dabigatran |
| 11 | Hexyl ((4-Aminophenyl)(imino)methyl)carbamate Hydrochloride | 1307233-93-7 | Dabigatran |
| 12 | 6-(4-Amino-2,6-dichlorophenoxy)-4-isopropylpyridazin-3(2H)-one | 920509-28-0 | Resmetirom |
| 13 | Ethyl (2-cyanoacetyl)carbamate | 6629-04--5 | Resmetirom |
| 14 | 3-fluorobenzene-1-sulfonyl chloride | 701-27-9 | Fexuprazan |
Disclaimer:
Product under patent will not be sold until patent expiration in buyers country purchase of any patented product will be sole responsibility of the buyer